{
    "organizations": [],
    "uuid": "9d54c6f119e80d3ac14fe72f58e6b88b35984a29",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangdong-zhongsheng-pharmaceutica/brief-guangdong-zhongsheng-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PQ5JT",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangdong Zhongsheng Pharmaceutical unit receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31(Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd\n* Says coâ€™s Guangdong-based wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for tablet, hard capsule, oral suspension, soft capsule and pill\n* Says valid period is until Jan. 18, 2023\nSource text in Chinese: goo.gl/Ad9TvT\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-31T21:51:00.000+02:00",
    "crawled": "2018-02-01T15:05:29.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "guangdong",
        "zhongsheng",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "co",
        "wholly",
        "owned",
        "pharmaceutical",
        "unit",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "guangdong",
        "food",
        "drug",
        "administration",
        "tablet",
        "hard",
        "capsule",
        "oral",
        "suspension",
        "soft",
        "capsule",
        "pill",
        "say",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}